The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XLI.a

Pulmonary edema, noncardiogenic (NCPE)

Publications

Amathieu R, Tual L, Fessenmeyer C, Dhonneur G

[Docetaxel-induced acute pulmonary capillary-leak syndrome mimicking cardiogenic oedema].

Annales francaises d'anesthesie et de reanimation 2007 Feb;26;180-1 — 2007 Feb — 180-1

Briasoulis E, Froudarakis M, Milionis HJ, Peponis I, Constantopoulos S, Pavlidis N

Chemotherapy-induced noncardiogenic pulmonary edema related to gemcitabine plus docetaxel combination with granulocyte colony-stimulating factor support.

Respiration; international review of thoracic diseases 2000;67;680-3 — 2000 — 680-3